Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Glycorex Transplantation AB (publ) (O33.F)

Compare
0.2030
0.0000
(0.00%)
As of 8:03:30 AM GMT+1. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
32,315
29,962
36,116
28,202
27,000
Cost of Revenue
5,653
3,108
4,572
3,264
2,370
Gross Profit
26,662
26,854
31,544
24,938
24,630
Operating Expense
51,805
57,195
39,956
36,753
32,383
Operating Income
-25,143
-30,341
-8,412
-11,815
-7,753
Net Non Operating Interest Income Expense
-370
3
-224
-269
-339
Pretax Income
-25,539
-30,364
-8,520
-12,241
-8,050
Tax Provision
--
--
56
2
-10
Net Income Common Stockholders
-25,539
-30,364
-8,576
-12,243
-8,040
Diluted NI Available to Com Stockholders
-25,539
-30,364
-8,576
-12,243
-8,040
Basic EPS
-0.34
-0.41
-0.12
-0.17
-0.11
Diluted EPS
-0.34
-0.41
-0.12
-0.17
-0.11
Basic Average Shares
73,853.9830
73,853.9830
73,853.9830
73,853.9830
73,590.7320
Diluted Average Shares
73,853.9830
73,853.9830
73,853.9830
73,853.9830
73,590.7320
Total Operating Income as Reported
-25,077
-30,275
-8,309
-11,844
-7,724
Total Expenses
57,458
60,303
44,528
40,017
34,753
Net Income from Continuing & Discontinued Operation
-25,539
-30,364
-8,576
-12,243
-8,040
Normalized Income
-25,539
-30,364
-8,618.8760
-12,243
-8,040
Interest Income
--
292
23
--
--
Interest Expense
--
289
247
269
339
Net Interest Income
-370
3
-224
-269
-339
EBIT
-24,877
-30,075
-8,273
-11,972
-7,711
EBITDA
-3,245
-8,739
284
-3,477
119
Reconciled Cost of Revenue
5,653
3,108
4,572
3,264
2,370
Reconciled Depreciation
21,632
21,336
8,557
8,495
7,830
Net Income from Continuing Operation Net Minority Interest
-25,539
-30,364
-8,576
-12,243
-8,040
Total Unusual Items Excluding Goodwill
--
--
54
--
-644
Total Unusual Items
--
--
54
--
-644
Normalized EBITDA
-3,245
-8,739
230
-3,477
119
Tax Rate for Calcs
--
--
0.0002
0.0002
0
Tax Effect of Unusual Items
--
--
11.1240
--
--
12/31/2020 - 8/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade